BROADPEAK (ALBPK.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:ALBPK • FR001400AJZ7

2.35 EUR
-0.08 (-3.29%)
Last: Feb 5, 2026, 07:00 PM
Fundamental Rating

3

ALBPK gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 32 industry peers in the Communications Equipment industry. Both the profitability and financial health of ALBPK have multiple concerns. While showing a medium growth rate, ALBPK is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year ALBPK has reported negative net income.
  • In the past year ALBPK had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ALBPK reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: ALBPK reported negative operating cash flow in multiple years.
ALBPK.PA Yearly Net Income VS EBIT VS OCF VS FCFALBPK.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • With a Return On Assets value of -2.14%, ALBPK perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
  • ALBPK has a Return On Equity (-5.68%) which is in line with its industry peers.
Industry RankSector Rank
ROA -2.14%
ROE -5.68%
ROIC N/A
ROA(3y)-4.48%
ROA(5y)0.39%
ROE(3y)-10.87%
ROE(5y)10.06%
ROIC(3y)N/A
ROIC(5y)N/A
ALBPK.PA Yearly ROA, ROE, ROICALBPK.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

  • ALBPK's Gross Margin of 96.77% is amongst the best of the industry. ALBPK outperforms 100.00% of its industry peers.
  • ALBPK's Gross Margin has improved in the last couple of years.
  • ALBPK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 96.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.66%
GM growth 5YN/A
ALBPK.PA Yearly Profit, Operating, Gross MarginsALBPK.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 60 80 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • ALBPK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALBPK has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, ALBPK has an improved debt to assets ratio.
ALBPK.PA Yearly Shares OutstandingALBPK.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALBPK.PA Yearly Total Debt VS Total AssetsALBPK.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • Based on the Altman-Z score of 1.22, we must say that ALBPK is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ALBPK (1.22) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.45 indicates that ALBPK is not too dependend on debt financing.
  • The Debt to Equity ratio of ALBPK (0.45) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 1.22
ROIC/WACCN/A
WACC8.26%
ALBPK.PA Yearly LT Debt VS Equity VS FCFALBPK.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • ALBPK has a Current Ratio of 1.19. This is a normal value and indicates that ALBPK is financially healthy and should not expect problems in meeting its short term obligations.
  • ALBPK has a worse Current ratio (1.19) than 78.13% of its industry peers.
  • ALBPK has a Quick Ratio of 1.19. This is a normal value and indicates that ALBPK is financially healthy and should not expect problems in meeting its short term obligations.
  • ALBPK has a Quick ratio (1.19) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
ALBPK.PA Yearly Current Assets VS Current LiabilitesALBPK.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 78.22% over the past year.
  • The Revenue has grown by 15.01% in the past year. This is quite good.
  • ALBPK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.93% yearly.
EPS 1Y (TTM)78.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.02%
Revenue 1Y (TTM)15.01%
Revenue growth 3Y5.93%
Revenue growth 5YN/A
Sales Q2Q%26.16%

3.2 Future

  • ALBPK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.92% yearly.
  • The Revenue is expected to grow by 9.09% on average over the next years. This is quite good.
EPS Next Y43.55%
EPS Next 2Y50.27%
EPS Next 3Y42.92%
EPS Next 5YN/A
Revenue Next Year12.06%
Revenue Next 2Y9.34%
Revenue Next 3Y9.09%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALBPK.PA Yearly Revenue VS EstimatesALBPK.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALBPK.PA Yearly EPS VS EstimatesALBPK.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALBPK. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 28.52, ALBPK can be considered very expensive at the moment.
  • ALBPK's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of ALBPK to the average of the S&P500 Index (27.20), we can say ALBPK is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 28.52
ALBPK.PA Price Earnings VS Forward Price EarningsALBPK.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALBPK indicates a somewhat cheap valuation: ALBPK is cheaper than 65.63% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.31
ALBPK.PA Per share dataALBPK.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • ALBPK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ALBPK's earnings are expected to grow with 42.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.27%
EPS Next 3Y42.92%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ALBPK!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BROADPEAK

EPA:ALBPK (2/5/2026, 7:00:00 PM)

2.35

-0.08 (-3.29%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners2.88%
Inst Owner ChangeN/A
Ins Owners49.73%
Ins Owner ChangeN/A
Market Cap29.47M
Revenue(TTM)43.87M
Net Income(TTM)-1.04M
Analysts86
Price Target3.42 (45.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.52%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-75%
EPS NY rev (3m)-133.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 28.52
P/S 0.67
P/FCF N/A
P/OCF 4.83
P/B 1.6
P/tB 107.16
EV/EBITDA 16.31
EPS(TTM)-0.09
EYN/A
EPS(NY)0.08
Fwd EY3.51%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.49
OCFY20.72%
SpS3.5
BVpS1.47
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.14%
ROE -5.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 96.77%
FCFM N/A
ROA(3y)-4.48%
ROA(5y)0.39%
ROE(3y)-10.87%
ROE(5y)10.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.66%
GM growth 5YN/A
F-Score6
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 3.5
Cap/Depr 111.77%
Cap/Sales 16.58%
Interest Coverage N/A
Cash Conversion 259.72%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z 1.22
F-Score6
WACC8.26%
ROIC/WACCN/A
Cap/Depr(3y)283.73%
Cap/Depr(5y)362.99%
Cap/Sales(3y)24.24%
Cap/Sales(5y)18.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.02%
EPS Next Y43.55%
EPS Next 2Y50.27%
EPS Next 3Y42.92%
EPS Next 5YN/A
Revenue 1Y (TTM)15.01%
Revenue growth 3Y5.93%
Revenue growth 5YN/A
Sales Q2Q%26.16%
Revenue Next Year12.06%
Revenue Next 2Y9.34%
Revenue Next 3Y9.09%
Revenue Next 5YN/A
EBIT growth 1Y54.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year182.46%
EBIT Next 3Y54.33%
EBIT Next 5YN/A
FCF growth 1Y84.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.99%
OCF growth 3Y167.99%
OCF growth 5YN/A

BROADPEAK / ALBPK.PA FAQ

What is the fundamental rating for ALBPK stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALBPK.PA.


What is the valuation status of BROADPEAK (ALBPK.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to BROADPEAK (ALBPK.PA). This can be considered as Overvalued.


Can you provide the profitability details for BROADPEAK?

BROADPEAK (ALBPK.PA) has a profitability rating of 3 / 10.


What is the financial health of BROADPEAK (ALBPK.PA) stock?

The financial health rating of BROADPEAK (ALBPK.PA) is 3 / 10.